Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.13.23283824250700.7173
Domestic EquitiesDr. Reddy's Laboratories Ltd.9.50224250104503.1698
Domestic EquitiesCipla Ltd.8.63052948259457.0096
Domestic EquitiesDivi's Laboratories Ltd.7.8079679240413.4534
Domestic EquitiesAurobindo Pharma Ltd.7.04643035780373.1277
Domestic EquitiesLupin Ltd.4.43471120591234.8310
Domestic EquitiesAlkem Laboratories Ltd.4.3034445422227.8779
Domestic EquitiesZydus Lifesciences Ltd.3.88612316699205.7808
Domestic EquitiesGland Pharma Ltd.3.61941369000191.6600
Domestic EquitiesSyngene International Ltd.2.20501841498116.7602
Domestic EquitiesApollo Hospitals Enterprise Ltd.1.8918143581100.1765
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.7681106932493.6247
Domestic EquitiesPfizer Ltd.1.761221724493.2585
Domestic EquitiesMankind Pharma Ltd1.727737110191.4875
Domestic EquitiesBiocon Ltd.1.6120265254285.3588
Domestic EquitiesWindlas Biotech Ltd.1.563885765182.8062
Domestic EquitiesMedplus Health Services Ltd1.517899695980.3698
Domestic EquitiesAdvanced Enzyme Technologies Ltd.1.3682253105672.4515
Domestic EquitiesMedi Assist Healthcare Services Ltd1.2749150409667.5113
Domestic EquitiesThyrocare Technologies Ltd.1.240374795565.6779
Domestic EquitiesShilpa Medicare Ltd.1.176996314962.3206
Domestic EquitiesFine Organic Industries Ltd.1.157315024361.2811
Domestic EquitiesYatharth Hospital & Trauma Care Services Pvt Ltd1.0614116192556.2023
Domestic EquitiesAarti Industries Ltd.1.0496131934755.5775
Domestic EquitiesSanofi Consumer Healthcare India Ltd1.000110719952.9563
Domestic EquitiesGlenmark Pharmaceuticals Ltd.0.988137882252.3229
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.9654350248151.1187
Domestic EquitiesFDC Ltd.0.9522119768950.4227
Domestic EquitiesAarti Drugs Ltd.0.9288140927349.1836
Domestic EquitiesDr Lal Pathlabs Ltd.0.922717644148.8583
Domestic EquitiesAstrazeneca Pharma India Ltd.0.90205502147.7637
Domestic EquitiesMax Financial Services Ltd.0.831133723044.0085
Domestic EquitiesProcter & Gamble Health Ltd.0.74877801239.6457
Domestic EquitiesStar Health & Allied Insurance0.665990462135.2621
Domestic EquitiesSenores Pharmaceuticals Ltd0.612664088332.4415
Domestic EquitiesEmcure Pharmaceuticals Ltd.0.574329761230.4130
Domestic EquitiesGalaxy Surfactants Ltd.0.407910424821.5981
Domestic EquitiesAtul Ltd.0.35672799918.8881
Domestic EquitiesUnichem Laboratories Ltd.0.274224103014.5196
Domestic EquitiesLaxmi Organic Industries Ltd.0.223967764811.8568
Domestic EquitiesLaxmi Dental Ltd.0.15012028987.9465
Total 96.3436 5101.6980
Cash & Cash Equivalents and Net AssetsTREPS3.2759 173.4679
Cash & Cash Equivalents and Net AssetsNet Current Assets0.2218 11.7443
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.1587 8.4052
Total 3.6564 193.6174
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.